Infective endocarditis is a growing problem with many shifts due to ever-increasing comorbid illnesses, invasive procedures, and increase in the elderly. We performed this multinational study to depict definite infective endocarditis. Adult patients with definite endocarditis hospitalized between January 1, 2015, and October 1, 2018, were included from 41 hospitals in 13 countries. We included microbiological features, types and severity of the disease, complications, but excluded therapeutic parameters. A total of 867 patients were included. A total of 631 (72.8%) patients had native valve endocarditis (NVE), 214 (24.7%) patients had prosthetic valve endocarditis (PVE), 21 (2.4%) patients had pacemaker lead endocarditis, and 1 patient had catheter port endocarditis. Eighteen percent of NVE patients were hospital-acquired. PVE patients were classified as early-onset in 24.9%. A total of 385 (44.4%) patients had major embolic events, most frequently to the brain (n = 227, 26.3%). Blood cultures yielded pathogens in 766 (88.4%). In 101 (11.6%) patients, blood cultures were negative. Molecular testing of vegetations disclosed pathogens in 65 cases. Overall, 795 (91.7%) endocarditis patients had any identified pathogen. Leading pathogens (Staphylococcus aureus (n = 267, 33.6%), Streptococcus viridans (n = 149, 18.7%), enterococci (n = 128, 16.1%), coagulasenegative staphylococci (n = 92, 11.6%)) displayed substantial resistance profiles. A total of 132 (15.2%) patients had cardiac abscesses; 693 (79.9%) patients had left-sided endocarditis. Aortic (n = 394, 45.4%) and mitral valves (n = 369, 42.5%) were most frequently involved. Mortality was more common in PVE than NVE (NVE (n = 101, 16%), PVE (n = 49, 22.9%), p = 0.042).
Introduction
Infective endocarditis (IE) is a growing problem in the world due to ever-increasing comorbid illnesses, invasive devices like intracardiac implants and prosthetic valves, frequent use of hemodialysis, and the increase of elderly population [1] . Despite advances in medical and surgical therapy, IE is associated with high mortality and severe complications [2, 3] . In order to achieve optimal outcomes in the management of IE, the clinical team must have an understanding of epidemiology, microbiology, and natural history of IE as well as guiding diagnostic principles and therapy. Until recently, guidelines on IE were mostly based on expert opinions due to absence of randomized trials and the limited number of meta-analyses. Hence, we performed this multinational study to depict the common presentations of IE, its microbiology, types, severity, and the complications to provide an insight into the current status of IE, and to compare the features of native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE) patients as the two leading endocardial infections.
Methods
Definite IE patients > 18 years old and hospitalized between January 1, 2015, and October 1, 2018, were included. Fortyone hospitals from 13 countries were involved. The data were recruited through Infectious Diseases International Research Initiative (ID-IRI), which serves as a network for clinical research (https://infectdisiri.wordpress.com/). The data input was made through a web-based questionnaire. The questionnaire included demographic, clinical, laboratory, microbiologic, special tests, and echocardiographic findings and outcome. Therapeutic concerns were not included. Ethical approval was obtained from the Fatih Sultan Mehmet Hospital in Istanbul and participants' respective Institutional Ethics Committees.
Definitions
Diagnoses of IE were made according to definitions below [4] . Echocardiogram positive for IE was defined as follows: oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation; abscess; or new partial dehiscence of prosthetic valve or new valvular regurgitation.
Minor criteria
(a) Predisposition, predisposing heart condition, or injection drug use (b) Fever, temperature > 38°C (c) Vascular phenomena, major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, and Janeway lesions (d) Immunological phenomena: glomerulonephritis, Osler nodes, Roth spots, and rheumatoid factor (e) Microbiological evidence: positive blood culture but does not meet a major criterion as noted above (excludes single positive cultures for coagulase negative staphylococci and organisms that do not cause endocarditis) or serological evidence of active infection with organism consistent with IE Definite IE Patients with 2 major criteria, 1 major criterion and 3 minor criteria, or 5 minor criteria were classified as definite IE [4] .
Ejection fraction value A normal heart's ejection fraction (EF) was accepted to be between 50 and 70% [5] .
Pulmonary hypertension If pulmonary artery pressure is greater than 25 mmHg at rest or 30 mmHg during physical activity, this was defined as pulmonary hypertension [6] .
Timing of IE according to implantation of prosthetic valves
Early-onset illness was classified as PVE within 1 year and late onset was defined as PVE after 1 year of valve surgery.
Histopathology Histopathological interpretation of removed cardiac vegetations was made as acute and subacute [7] .
Onset timings of IE This was determined according to start of symptoms.
Statistical analysis Descriptive statistics were presented as frequency and percent or mean ± standard deviation (SD) and range as appropriate. Chi-square and Fisher's exact tests were used to compare categorical variables and Student's t test and Mann-Whitney U test were used for comparisons of continuous variables. A P value of < 0.05 was considered significant.
Results
A total of 867 cases with definite IE were included from 41 referral centers in 13 countries (Albania (n = 12), Belgium (n = 26), Denmark (n = 13), France (n = 205), Israel (n = 55), Italy (n = 66), Jordan (n = 7), Pakistan (n = 27), Portugal (n = 86), Romania (n = 16), Saudi Arabia (n = 22), Slovenia (n = 10), Turkey (n = 322)). A total of 292 (33.7%) patients were females and the median age was 59.5 (16-96) years. A total of 711 cases had 2 major criteria and 136 patients had 1 major and ≥ 3 minor criteria. Likely sources of IE were specified by the treating clinicians in 515 cases (NVE (n = 401), PVE (n = 107), pacemaker IE (n = 6), catheter port IE (n = 1)) ( Table 1 ). The mean likely onset timings of IE were 34.2 ± 59 days for NVE and 52 ± 164 days for PVE (p = 0.049).
Diagnostic issues

Embolic events
(a) Arterial emboli: 385 (44.4%) patients had major embolic events. The distribution of embolisms was as follows: cerebral (n = 227, 26.3%), splenic (n = 59, 6.8%), pulmonary (n = 53, 6.1%), renal (n = 25, 2.9%), peripheral (n = 20, 2.2%), coronary (n = 4), mesenteric (n = 3). In 301 (43.4%) of 693 left-sided IE and 40 (39.2%) of 102 right-sided IE, major arterial embolism was detected (Table 3) . (b) Other vascular phenomena: Janeway lesions (n = 34, 3.9%), mycotic aneurysm (n = 8), splinter hemorrhage (n = 4), and conjunctival hemorrhage (n = 4). Staphylococcus aureus (n = 267, 33.6%), Streptococcus viridans (n = 149, 18.7%), enterococci (n = 128, 16.1%), coagulase-negative staphylococci (CoNS; n = 92, *N indicates the denominator with any specified likely source A P value of <0.05 was considered significant 11.6%), and enteric Gram-negative bacilli (n = 50, 6.3%). The causative agents are presented in Table 2 . Blood cultures yielded pathogens in 18 and vegetation cultures in 6 patients for pacemaker IE. A total of 18 of 21 cases had an identified pathogen in pacemaker IE (S. aureus (n = 12), CoNS (n = 3), Enterococcus faecalis (n = 1), Streptococcus pneumoniae (n = 1), S. viridans (n = 1)). CoNS were isolated from the blood culture of a patient with catheter port IE. The distributions and comparisons of infecting pathogens for PVE and NVE are presented in Table 2 . There were 18 (2%) probable zoonotic agents (C. burnetii (9 cases), Bartonella quintana (4 cases), and Brucella spp. (5 cases)). (c) Etiology of cardiac abscesses: In 10 out of 132 patients with cardiac abscesses, the causative agents could not be recovered. A total of 128 pathogens were recovered in 122 patients. They were S. aureus (n = 36, 27.3%), enterococci (n = 24, 18.2%) (untyped Acinetobacter Iwoffii n = 5, E. faecalis n = 19), S. viridans (n = 20, 15.1%), CoNS (n = 18, 13.5%), enteric Gram-negatives (Escherichia coli (n = 3), Klebsiella oxytoca (n = 3), Enterobacter cloacae (n = 3), C. burnetii (n = 2), Enterobacter aerogenes (n = 1), Salmonella dublin (n = 1), Salmonella enteridis (n = 1)), Streptococcus dysgalactiae (n = 1), Streptococcus pseudoporcinus (n = 1)], Micrococcus luteus (n = 1), Brucella spp. (n = 1), Acinetobacter baumannii (n = 1), Pseudomonas aeruginosa (n = 1), Neisseria gonorrhoeae (n = 1), Prevotella bivia (n = 1), Bacillus cereus (n = 1), Corynebacterium jeikeium (n = 1), Lactobacillus rhamnosus (n = 1), Aggregatibacter aphrophilus (n = 1), Candida albicans (n = 2), Candida tropicalis (n = 1). (d) Major resistance issues: 73 out of 267 (27.3%) of S. aureus strains were methicillin resistant. Nine out of 128 (7%) enterococci were vancomycin resistant (VRE). Antibiotic susceptibility was recorded in 88 of 149 S. viridans strains and 24 strains were penicillin resistant (27.3%).
2.
Radiological data
(a) Imaging modalities: Transthoracic echocardiography (n = 544), transesophageal echocardiography (n = 464), positron-emission tomography (n = 18), 3-dimensional echocardiography (n = 14), cardiac magnetic resonance imaging (n = 6), and head-to-toe multislice computed tomography (n = 5) were the radiological methods used. Underlying noncardiac disorders Hypertension (n = 410, 47.2%), diabetes mellitus (n = 231, 26.6%), hyperlipidemia (n = 192, 22.1%), chronic renal failure (n = 103, 11.9%), chronic obstructive pulmonary disease (n = 85, 9.8%), hemodialysis (n = 79, 9.1%), malignancy (n = 77, 8.9%), use of extended intravenous catheter (n = 66, 7.6%), immunosuppressive drug use (n = 53, 6.1%), cerebrovascular accident (n = 53, 6.1%), IV drug addiction (n = 52, 6.1%), poor dental care (n = 35, 4%), collagenosis (n = 23, 2.7%), HIV infection (n = 14, 1.6%), alcoholism (n = 11, 1.3%), hepatitis B (n = 3, 0.3%), and hepatitis C (n = 3, 0.3%) are the underlying noncardiac disorders.
Mortality Intrahospital mortality was 17.5% (n = 152).
Treating clinicians have specified attributed 172 causes of death in 130 of 152 patients. Septic shock/multiorgan failure (n = 86, 66.2%), congestive heart failure (n = 40, 30.8%), cerebral embolism/hemorrhage (n = 23, 17.7%), myocardial infarction (n = 10, 7.7%), surgical complications (n = 6, 4.6%), atrioventricular block (n = 3, 2.3%), mesenteric ischemia (n = 3, 2.3%), and liver failure (n = 1, 0.8%) were the likely reasons of death. PVE was found to be significantly mortal than NVE (NVE (n = 101, 16%), PVE (n = 49, 22.9%), (p = 0.042)).
Discussion
Epidemiology of IE has become more complex with today's myriad healthcare-associated factors predisposing infections. *Valvular problems due to rheumatic heart disease (n = 26) are also presented in related lines. **One isolated catheter port endocarditis is not included in the columns
In this study, one-fourth of our cases were PVE and almost three-fourth were NVE. If left untreated, IE can rapidly destroy heart valves and may lead to life-threatening consequences [4, 8] . Our data showed that 44% of the patients had experienced major arterial embolism and 15% had cardiac abscesses. Hence, blood cultures, echocardiography, and major arterial embolism were decisive in the diagnosis of IE rather than immunological and the rest of vascular phenomena. Moreover, 17% of NVE patients had experienced valve perforations while one-third of PVE cases had prosthetic valve dysfunction as the catastrophic consequences. Finally, 17.5% of the IE cases have lost their lives and mortality was significantly higher in the PVE arm compared with that of NVE patients. Septic shock, congestive heart failure, and cerebral embolism have been the leading potential causes of death in descending order in this study. Today, global life expectancy at the age of 60 is around 20 years [9] and this increases the population vulnerable to IE due to underlying cardiac disorders other than rheumatic diseases [10] . We have found that both coexistent valvular problems and cardiac implants made up one-third of the patients for each as the foremost cardiac problems. Historically, prosthetic heart valve implantation was first performed on aortic valves in 1960 [11] . Today, all cardiac valves can be implanted and more than half of PVE was at the aortic valves followed by mitral valve involvement in our study. Conversely, there are preliminary data of uninfected prosthetic valves in patients with coexistent NVE [12] . We have shown that 7.4% of the NVE patients had uninfected cardiac implants.
In this study, 93.4% of the patients had cardiac vegetations compatible definite IE [4] . Four-fifths, as the significant portion, of patients had left-sided IE affecting aortic and mitral valves with similar rates. Although relatively infrequent [13] , we detected multivalvular involvement in one-tenth of our cases. Basically, size matters in endocarditis and bigger vegetations, over 10 mm in particular, boost embolic risks [14] .
Hence, patients exceeding 10 mm of vegetations commonly become candidates for surgery [4] . In this study, the vegetation sizes were not different between NVE and PVE patients, and it was slightly more than 13 mm for both groups indicating the serious potential to produce embolism [4] . Accordingly, more than one-third of our patients experienced cardiac surgery. Besides, cardiac abscesses were detected in 15.2% of the patients. Mostly single organisms are known to cause cardiac abscesses [15] and this was typically the case in our study. S. aureus was the leading pathogen in more than one-fourth of the abscess patients followed by enterococci and CoNS. IE due to CoNS is increasingly being recognized and associated with more frequent abscess formation compared with S. aureus in PVE patients [16] . Besides, we found that patients with PVE had longer durations until the establishment of diagnosis, and abscesses and cardiac fistulas were more frequent in PVE patients [17] . Accordingly, when the removed vegetations were analyzed histopathologically, half was reported as acute, and the other half was subacute that may ease the development of suppurative complications. Hence, PVE seemingly corrodes the heart higher than NVE and this also supported by the decreased ventricular ejection fraction and higher mortality rate in this study.
Staphylococcal species have long been known as dominant causative agents in IE [4, 8] . In a recent systematic review, staphylococcal IE percentage increased in the last five decades, S. aureus from 21 to 30% in particular [1] . In this study, staphylococcal species on the whole made up more than twofifths of all cases. In previous reports, enterococci were related to late PVE [18] or CoNS was recorded as being increasingly recognized in PVE patients [16] . We have disclosed that S. aureus was significantly more frequent in NVE while enterococci and CoNS were more common pathogens in PVE patients. Moreover, our data mark the need for extensive empirical antibiotic coverage since both a diverse group of pathogens in general and multiple microorganisms (2.5%) in particular were recovered. Since more than one-fourth of S. aureus strains were methicillin resistant and penicillin resistance was detected in more than one-fourth of S. viridans strains, the empirical use of vancomycin or daptomycin should be considered in accordance with the local susceptibility data. Although preliminary data stressed the importance of hospital-acquired pathogens [19] , our data disclosed that as much as 18% of NVE cases were classified under hospitalacquired infection category. Furthermore, dental source, central catheters, and respiratory system appeared to be more significant sources in NVE while cardiac surgery was commonly associated to PVE. Consequently, these data stress the importance of infection control practices.
Culture-negative endocarditis, which has been known to increase, is a serious concern in the optimization of therapy [20] . We found that slightly more than one-tenth of the cases were culture-negative. This is mostly due to early use of antibiotics prior to blood cultures, raised incidence of zoonotic diseases, and standardization problems in microbiological tests [21] . However, zoonotic endocarditis agents, known to be common in low-income countries [20] , were infrequent (2%) in our study. This datum indicates the necessity of improved diagnostic approaches in IE. Accordingly, cultures and molecular testing from the removed cardiac vegetations contributed an additional 3.3% diagnosis in this study. IE is often accompanied by complications [2, 3] , primarily the systemic embolic events due to migrating endocardial vegetations [14] . In a recent meta-analysis, embolism was significantly higher in intravenous drug users, HIVand chronic liver disease patients, during staphylococcal infections, and with multiple, mobile, or mitral valve vegetations, and when the vegetation size is over 10 mm, or in PVE patients [22] . These parameters were exceedingly common in our cohort with the resultant arterial emboli in 44.4% of the cases. Cerebral embolism was the leading cause of arterial emboli in more than one-fourth of the cases. We could not disclose a difference for embolic potential between right-and left-sided endocarditis. However, the brain was significantly the more frequent site of embolism in left-sided while lungs were primary targets in right-sided IE.
The strengths of this study are the inclusion of definite endocarditis cases and its multicenter design. Its weaknesses are the retrospective nature and potential geographical differences in microbiological procedures. In conclusion, endocardial infections are primarily reported to be managed by cardiology, cardiovascular surgery, infectious diseases, and neurology departments as a teamwork [23] and our data stresses the importance of this collaboration. Furthermore, continuous surveillance, multidisciplinary patient management, infection control, and diagnostic improvement are crucial issues in the management of disease.
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